StonvexLoading…
StonvexCore line items from ADM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $24.96B | $24.37B | $25.69B | $27.61B |
Operating Income | $1.25B | $2.25B | $4.29B | $5.23B |
Net Income | $1.08B | $1.80B | $3.48B | $4.34B |
EPS (Diluted) | $2.23 | $3.65 | $6.43 | $7.71 |
Total Assets | $52.39B | $53.27B | $54.63B | $59.77B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.01B | $611.00M | $1.37B | $1.04B |
Free Cash Flow OCF − CapEx | $4.20B | $1.23B | $2.97B | $2.16B |
Shares Outstanding | 484.00M | 493.00M | 542.00M | 563.00M |